检索结果 - Jon Rowland

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Amifostine does not prevent platinum‐induced hearing loss associated with the treatment of children with hepatoblastoma

    Amifostine does not prevent platinum‐induced hearing loss associated with the treatment of children with hepatoblastoma 由 Howard M. Katzenstein, Kay W. Chang, Mark Krailo, Zhengjia Chen, Milton J. Finegold, Jon Rowland, Marleta Reynolds, Alberto S. Pappo, Wendy B. London, Marcio H. Malogolowkin

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Intensified Platinum Therapy Is an Ineffective Strategy for Improving Outcome in Pediatric Patients With Advanced Hepatoblastoma

    Intensified Platinum Therapy Is an Ineffective Strategy for Improving Outcome in Pediatric Patients With Advanced Hepatoblastoma 由 Marcio H. Malogolowkin, Howard M. Katzenstein, Mark Krailo, Zhengjia Chen, Laura C. Bowman, Marleta Reynolds, Milton J. Finegold, Brian Greffe, Jon Rowland, Kurt D. Newman, Richard B. Womer, Wendy B. London, Robert P. Castleberry

    出版 2006
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Mutations in KAT6B, Encoding a Histone Acetyltransferase, Cause Genitopatellar Syndrome

    Mutations in KAT6B, Encoding a Histone Acetyltransferase, Cause Genitopatellar Syndrome 由 Philippe M. Campeau, Jaeseung Kim, James T. Lu, Jeremy Schwartzentruber, Omar Abdul‐Rahman, Silke Schlaubitz, David M. Murdock, Ming-Ming Jiang, Edward J. Lammer, Gregory M. Enns, William J. Rhead, Jon Rowland, Stephen P. Robertson, Valérie Cormier‐Daire, Matthew N. Bainbridge, Xiang‐Jiao Yang, Marie‐Claude Gingras, Richard A. Gibbs, David S. Rosenblatt, Jacek Majewski, Brendan Lee

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: